Success Item Removed From Cart

Basket Summary
Close

Your Cart is Empty

Subtotal
$0
Sales Tax
$0
Total
$0
Back to browsing

Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Report Overview

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. These three types are members of the Orthomyxoviridae family and are structurally related.

The Seasonal Influenza Prophylactics marketed, and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, pricing and reimbursement, late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR), and Likelihood of Approval (LoA) for Seasonal Influenza Prophylactics (SIP).

Leading Marketed Vaccines in Influenza

A few of the leading marketed vaccines in influenza market are Fluzone QIV HD, Fluarix Quadrivalent, and Afluria QIV among others. The seasonal influenza vaccine market is dominated by highly competitive players and products of relatively similar efficacy and safety. Due to the complexity of vaccine manufacturing, generics are not available in the influenza vaccine market. This protective environment has limited the 16MM to large pharmaceutical firms such as Sanofi, GSK, Seqirus, Mylan, and AstraZeneca.

Top Sponsors in the Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Market

A few of the top sponsors in the Seasonal Influenza Prophylactics marketed and pipeline drugs market are The National Institute of Allergy and Infectious Diseases, Moderna Inc, GSK plc, Stanford University, Sinovac Biotech Ltd, Seqirus Ltd, Novavax Inc, Vaxart Inc, Novartis AG, and Sanofi.

Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Sponsors Analysis

Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Sponsors Analysis

Buy the full Report for More Sponsor Insights into the Seasonal Influenza Prophylactics Marketed and Pipeline Drugs, Download a Free Report Sample

Seasonal Influenza Prophylactics Marketed Drugs Segmentation by Routes of Administration

The key routes of administration for Seasonal Influenza Prophylactics marketed drugs are injection and inhalational. Most marketed vaccines for influenza are injectable products.

Seasonal Influenza Prophylactics Marketed Drugs Analysis, by Routes of Administration

Seasonal Influenza Prophylactics Marketed Drugs Analysis, by Routes of Administration

Buy the full Report for More RoA Insights into the Seasonal Influenza Prophylactics Marketed Drugs, Download a Free Report Sample

Seasonal Influenza Prophylactics Pipeline Drugs Segmentation by Routes of Administration

The key routes of administration for Seasonal Influenza Prophylactics pipeline drugs are oral, injection, topical, and inhalational. Of all the influenza pipeline vaccines, injection is the most common route of administration.

Seasonal Influenza Prophylactics Pipeline Drugs Analysis, by Routes of Administration

Seasonal Influenza Prophylactics Pipeline Drugs Analysis, by Routes of Administration

Buy the full Report for More RoA Insights into the Seasonal Influenza Prophylactics Pipeline Drugs, Download a Free Report Sample

Seasonal Influenza Prophylactics Marketed and Pipeline Drugs – Deals Landscape

  • On 1st Nov 2022, Seqirus (CSL Seqirus) Enters into Licensing Agreement with Arcturus Therapeutics
  • On 12th Oct 2022, Emergex Vaccines Acquires Zosano Pharma

Buy the full Report for More Deal Insights into the Seasonal Influenza Prophylactics Marketed and Pipeline Drugs, Download a Free Report Sample

Key Molecule Type (Marketed) ·        Biologic
Key Routes of Administration (Marketed) ·        Injection

·        Inhalational

Key Routes of Administration (Pipeline) ·        Oral

·        Injection

·        Topical

·        Inhalational

Top Sponsors (Marketed and Pipeline Drugs) ·        The National Institute of Allergy and Infectious Diseases

·        Moderna Inc

·        GSK plc

·        Stanford University

·        Sinovac Biotech Ltd

·        Seqirus Ltd

·        Novavax Inc

·        Vaxart Inc

·        Novartis AG

·        Sanofi

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Segments Covered in the Report

Seasonal Influenza Prophylactics Marketed Drugs Market Molecule Types Outlook (Number of Products)

  • Biologic

Seasonal Influenza Prophylactics Marketed Drugs Market Routes of Administration Outlook (Number of Products)

  • Injection
  • Inhalational

Seasonal Influenza Prophylactics Pipeline Drugs Market Routes of Administration Outlook (Number of Products)

  • Oral
  • Injection
  • Topical
  • Inhalational

Scope of Report

GlobalData’s Seasonal Influenza Prophylactics Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.

Components of the report include:

  • Disease Landscape
  • Disease Overview
  • Epidemiology Overview
  • Treatment Overview
  • Marketed Products Assessment
  • Breakdown by Mechanism of Action, Molecule Type, Route of Administration
  • Product Profiles with Sales Forecast
  • Pricing and Reimbursement Assessment
  • Annual Therapy Cost
  • Time to Pricing and Time to Reimbursement
  • Pipeline Assessment
  • Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
  • Product Profiles with Sales Forecast
  • Late-to-mid-stage Pipeline Drugs
  • Phase Transition Success Rate and Likelihood of Approval
  • Clinical Trials Assessment
  • Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
  • Enrolment Analytics, Site Analytics, Feasibility Analysis
  • Deals Landscape
  • Mergers, Acquisitions, and Strategic Alliances by Region
  • Overview of Recent Deals
  • Commercial Assessment
  • Key Market Players
  • Future Market Catalysts

Reasons to buy

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the Influenza Prophylactics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Influenza Prophylactics market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

FAQs

  • The molecule type in the Seasonal Influenza Prophylactics marketed drugs is biologic.

  • The key routes of administration in the Seasonal Influenza Prophylactics marketed drugs are injection and inhalational.

  • The key routes of administration in the Seasonal Influenza Prophylactics pipeline drugs are oral, injection, topical, and inhalational.

  • The top sponsors in the Seasonal Influenza Prophylactics marketed and pipeline drugs market are The National Institute of Allergy and Infectious Diseases, Moderna Inc, GSK plc, Stanford University, Sinovac Biotech Ltd, Seqirus Ltd, Novavax Inc, Vaxart Inc, Novartis AG, and Sanofi.

What our clients have to say

More Reports

View More Reports